Understanding and addressing anti-drug antibody formation in tumor necrosis factor-α inhibitor therapy for ankylosing spondylitis

QR Code

Understanding and addressing anti-drug antibody formation in tumor necrosis factor-α inhibitor therapy for ankylosing spondylitis

Saved in:

Bibliographic Details
Main Author:	Tae-Jong Kim
Format:	Article
Language:	English
Published:	Korean College of Rheumatology 2025-07-01
Series:	Journal of Rheumatic Diseases
Online Access:	http://www.jrd.or.kr/journal/view.html?doi=10.4078/jrd.2025.0067
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of inhibitors of tumor necrosis factor α in women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2021-10-01)

TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
by: S. A. Lapshina, et al.
Published: (2016-09-01)

Impact of therapy with tumor necrosis factor-α inhibitors on the working ability of patients with ankylosing spondylitis
by: Sh. F. Erdes, et al.
Published: (2016-03-01)

IMPACT OF THE THERAPY WITH TUMOR NECROSIS FACTOR α INHIBITORS ON THE FREQUENCY OF UVEITIS EXACERBATIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Alla A Godzenko, et al.
Published: (2014-03-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
by: Yu. V. Muravyev, et al.
Published: (2020-05-01)

Evaluation of the effects of tumor necrosis factor-а inhibitors versus nonsteroidal anti-inflammatory drugs on spinal inflammatory changes from magnetic resonance imaging data in patients with ankylosing spondylitis
by: Ekaterina Yuryevna Tyukhova, et al.
Published: (2012-06-01)

Choice of a nonsteroidal anti-inflammatory drug in ankylosing spondylitis
by: Rimma Mikhailovna Balabanova, et al.
Published: (2014-12-01)

Paradoxical pustular psoriasis induced by tumor necrosis factor inhibitor with elevated interferon-alpha in an ankylosing spondylitis patient: A case report
by: Tinh Khampaen, MD, et al.
Published: (2025-08-01)

Nonsteroidal anti-inflammatory drugs: a basis for the treatment of ankylosing spondylitis
by: A A Godzenko
Published: (2011-12-01)

Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis
by: V. I. Mazurov, et al.
Published: (2021-01-01)

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)

The survival rate of therapy with tumor necrosis factor-αinhibitors: main causes and drug substitution tactics
by: E. V. Igolkina, et al.
Published: (2018-12-01)

The development of universal alopecia during therapy with TNF-α inhibitors in patients with ankylosing spondylitis: description of three cases
by: M. V. Kireeva, et al.
Published: (2021-10-01)

Problems of prescribing nonsteroidal anti-inflammatory drugs for reproductive-aged women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2020-09-01)

Vessel wall stiffness in ankylosing spondylitis patients taking nonsteroidal anti-inflammatory drugs
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE
by: Olga Nikolayevna Egorova, et al.
Published: (2014-02-01)

The Prospects of tumor necrosis factor α inhibitors use in patients with COVID-19
by: E. S. Aronova, et al.
Published: (2021-04-01)

THE SEVERE COURSE OF DRUG THERAPY-RESISTANT ANKYLOSING SPONDYLITIS
by: D. G. Rumyantseva, et al.
Published: (2020-04-01)

Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings
by: Inna Zurabievna Gaidukova, et al.
Published: (2015-09-01)

Choice of therapeutic tactics after failure of the first tumor necrosis factor-α inhibitor
by: N. V. Chichasova
Published: (2017-09-01)

Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2022-12-01)

Remission in ankylosing spondylitis and axial spondyloarthritides: A modern understanding of the problem
by: I. Z. Gaydukova, et al.
Published: (2016-03-01)

Symptomatic therapy for ankylosing spondylitis
by: Vladimir Vasilyevich Badokin
Published: (2012-03-01)

Clinical Features of Ankylosing Spondylitis
by: Wolf, Jeanette
Published: (2012)

Early diagnosis of ankylosing spondylitis
by: Sh F Erdes, et al.
Published: (2013-11-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)

ANKYLOSING SPONDYLITIS IN THE VOLGA BULGARIA
by: D. I. Abdulganieva, et al.
Published: (2015-09-01)

LABORATORY BIOMARKERS FOR ANKYLOSING SPONDYLITIS
by: E. N. Aleksandrova, et al.
Published: (2017-03-01)

Heart damage in ankylosing spondylitis
by: A A Godzenko, et al.
Published: (2009-08-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: TATIANA A. Raskina, et al.
Published: (2019-03-01)

How real is the long-lasting effect of tumor necrosis factor α inhibitors? Focus on immunogenicity
by: D.E. Karateev
Published: (2014-05-01)

Efficacy of tumor necrosis factor-α inhibitors in the treatment of various immunoinflammatory diseases: focus on immunogenicity
by: T. Yu. Nuriahmetova, et al.
Published: (2023-08-01)

Tumor necrosis factor-α inhibitors and their effects on cardiovascular risk factorsin patients with rheumatoid arthritis
by: O G Lineva, et al.
Published: (2010-02-01)

INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE
by: O. P. Dudarenko, et al.
Published: (2016-01-01)

Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
by: R. M. Balabanova, et al.
Published: (2021-06-01)

Musculoskeletal losses in patients with ankylosing spondylitis
by: T. A. Raskina, et al.
Published: (2019-10-01)

Early diagnosis of coxitis in ankylosing spondylitis
by: Sh. F. Erdes, et al.
Published: (2023-08-01)

The abilities of golimumab in the therapy of ankylosing spondylitis
by: Sh. F. Erdes
Published: (2014-09-01)

HLA-B27 and Ankylosing Spondylitis
by: Tsai, Wen-Chan
Published: (2012)